Stefano Comai
Padova, 35131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Sex-sensitive serotonergic signaling in psychedelic pharmacology.
Journal: Trends in pharmacological sciences
Published: May 06, 2026
Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressants.
Journal: International clinical psychopharmacology
Published: February 27, 2026
Mutations in the three synapsin genes lead to profound social deficits and cortical dysfunctions.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: February 11, 2026
Structural and Dynamics Insights into Melatonin Binding to MT1 Receptor.
Journal: Chembiochem : a European journal of chemical biology
Published: February 04, 2026
Up-Regulation of Anthranilic Acid Formation and Pro-Cognitive Effect of Indoleamine 2,3-Dioxygenase Inhibition.
Journal: International journal of tryptophan research : IJTR
Published: February 02, 2026
Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N-Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure.
Journal: Journal of medicinal chemistry
Published: January 26, 2026
Schizophrenia and frontotemporal dementia: distinct diseases with converging circuit dysfunctions.
Journal: Neuroscience
Published: November 03, 2025
Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms.
Journal: Pharmacological research
Published: October 30, 2025
Neurophysiological and neuropharmacological effects of melatonin MT2 receptors activation in MK-801-induced schizophrenia-like dysfunctions.
Journal: Biochemical pharmacology
Published: October 28, 2025
Cannabidiol (CBD) modulates the serotonin-kynurenine metabolic balance in the brain of morphine-tolerant neuropathic rats.
Journal: Pharmacological reports : PR
Published: October 27, 2025
Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Antidepressant Tachyphylaxis: An Exploratory Post Hoc Analysis From a Phase 3 Randomized Controlled Trial.
Journal: The Journal of clinical psychiatry
Published: October 08, 2025
Last Updated: 09/26/2026